Skip to main content
. 2012 Mar 9;53(3):1244–1250. doi: 10.1167/iovs.11-8668

Figure 7.

Figure 7.

Schematic diagram summarizing the mechanisms via which anti-VEGF-C therapy suppress alloimmunity. VEGF-C binding to VEGFR-2 and VEGFR-3 induces hemangiogenesis and lymphangiogenesis, respectively. VEGF-C also promotes maturation and migration of APC to lymphoid tissues. iAPCs, immature antigen-presenting cells; mAPCs, mature antigen-presenting cells.